Chemosensory data were also collected in a larger NHANES sample in 2013-2014. The prevalence of smell disorder (scores 0-5 out of 8 correct) was 13.5% in persons aged 40 years and over. If the same prevalence occurred in 2016, an estimated 20.5 million persons 40 and over had hyposmia or anosmia. In addition multiple demographic socioeconomic, and lifestyle characteristics were assessed as risk factors for diminished smell. In statistical analyses, greater age and male sex, coupled with either Black and/or non-Hispanic ethnicity, low family income, low educational attainment, high alcohol consumption (more than 4 drinks per day), and a history of asthma or cancer were independently associated with a greater prevalence of smell impairment. See also
Hyperosmia
Dysosmia
Anosmia


== References ==
Babies with SUA may have a higher likelihood of having other congenital abnormalities, especially of the heart. However, additional testing (high level ultrasound scans) can rule out many of these abnormalities prior to birth and alleviate parental anxiety.It may be associated with Trisomy 18, also known as Edwards syndrome. Intrauterine growth restriction has been found to be associated. Diagnosis
It can be detected in the first trimester of pregnancy with the use of 2D ultrasound. The sonographer is able to identify a 2 vessel cord in an image with the bladder and color Doppler, which will show only one artery going around one side of the bladder. In a normal fetus, there would be 2 arteries (one on each side of the bladder). Echocardiograms of the fetus may be advised to ensure the heart is functioning properly. Genetic counseling may be useful, too, especially when weighing the pros and cons of more invasive procedures such as chorionic villus sampling and amniocentesis. These invasive procedures are usually performed when there is a suspected chromosomal abnormality or genetic defect and will confirm a diagnosis. Prognosis
Although the presence of an SUA is a risk factor for additional complications, most fetuses with the condition will not experience other problems, either in utero or after birth. Especially encouraging are cases in which no other soft markers for congenital abnormalities are visible via ultrasound. Given that, the vast majority of expectant mothers do not receive the kind of advanced ultrasound scanning required to confirm SUA in utero.